120 related articles for article (PubMed ID: 38599643)
1. [Prediction of pathological remission of head and neck squamous cell carcinoma patients after neoadjuvant immunochemotherapy and construction of clinical model based on clinical features and inflammatory markers].
Lin QH; Yan SD; Zhang X; Chen SW; Li XY; Zhang Y; Zhang ST; Song M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):357-365. PubMed ID: 38599643
[No Abstract] [Full Text] [Related]
2. Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.
Leidner R; Crittenden M; Young K; Xiao H; Wu Y; Couey MA; Patel AA; Cheng AC; Watters AL; Bifulco C; Morris G; Rushforth L; Nemeth S; Urba WJ; Gough M; Bell RB
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963014
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemoimmunotherapy shows major pathological response and low recurrence in head and neck squamous cell carcinoma.
Yan S; Liu L; Zhang X; Wei L; Jiang W; Gao X; Yang A; Liu X; Chen W; Chen Y; Li H; Lin Q; Li M; Chen J; Zhang Q; Chen S; Song M
Clin Transl Oncol; 2024 May; 26(5):1192-1202. PubMed ID: 37989823
[TBL] [Abstract][Full Text] [Related]
4. Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma.
Wang Y; Song Y; Wang R; Wu Y; Li M; Xu K; He R; Wang Z; Li Q; Kong FS; Wang T
Front Oncol; 2024; 14():1265228. PubMed ID: 38680859
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of
Yin X; Li J; Chen B; Liu K; Hu S
Lung Cancer; 2023 Dec; 186():107389. PubMed ID: 37820538
[TBL] [Abstract][Full Text] [Related]
6. [
Vos JL; Zuur CL; Smit LA; de Boer JP; Al-Mamgani A; van den Brekel MWM; Haanen JBAG; Vogel WV
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2010-2022. PubMed ID: 34957526
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB-IIIB lung squamous cell carcinoma.
Liu J; Zhu L; Tang M; Huang X; Gu C; He C; Lv X; Hu J
Sci Rep; 2024 Mar; 14(1):5523. PubMed ID: 38448498
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer.
Liu C; Zhao W; Xie J; Lin H; Hu X; Li C; Shang Y; Wang Y; Jiang Y; Ding M; Peng M; Xu T; Hu A; Huang Y; Gao Y; Liu X; Liu J; Ma F
Front Immunol; 2023; 14():1115291. PubMed ID: 36875128
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial.
Wu D; Li Y; Xu P; Fang Q; Cao F; Lin H; Li Y; Su Y; Lu L; Chen L; Li Y; Zhao Z; Hong X; Li G; Tian Y; Sun J; Yan H; Fan Y; Zhang X; Li Z; Liu X
Nat Commun; 2024 Mar; 15(1):2177. PubMed ID: 38467604
[TBL] [Abstract][Full Text] [Related]
10. Tertiary lymphoid structures combined with biomarkers of inflammation are associated with the efficacy of neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: A retrospective study.
Xu F; Zhu H; Xiong D; Wang K; Dong Y; Li L; Yuan S
Thorac Cancer; 2024 Jan; 15(2):172-181. PubMed ID: 38057283
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial).
Huang Y; Sun J; Li J; Zhu D; Dong M; Dou S; Tang Y; Shi W; Sun Q; Zhao T; Zhou Z; Zhou X; Liu Y; Li J; Zhu G; Zhang D; Chen Y; Zhu Q; Ju W; Zhong L
Int J Surg; 2023 Aug; 109(8):2220-2227. PubMed ID: 37288582
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial.
Huang X; Liu Q; Zhong G; Peng Y; Liu Y; Liang L; Hong H; Feng W; Yang S; Zhang Y; Xian S; Li Z; Zhou Y; Zhang Z; Jiang W; Liang J; Liu ZG
J Exp Clin Cancer Res; 2022 Oct; 41(1):300. PubMed ID: 36224603
[TBL] [Abstract][Full Text] [Related]
13. Impact of treatment interval between neoadjuvant immunochemotherapy and surgery in lung squamous cell carcinoma.
Gu C; Teng X; Sun X; Liu J; Zhu Z; Zhang L; Wu Z; Zou R; Pang J; Lyu X
BMC Cancer; 2024 May; 24(1):585. PubMed ID: 38741038
[TBL] [Abstract][Full Text] [Related]
14. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
[No Abstract] [Full Text] [Related]
15. Development and validation of a nomogram to predict cervical lymph node metastasis in head and neck squamous cell carcinoma.
Chen X; Zhang L; Lu H; Tan Y; Li B
Front Oncol; 2023; 13():1174457. PubMed ID: 38282669
[TBL] [Abstract][Full Text] [Related]
16. [CD103
Li BW; Ren SQ; Chen SL; Lan TJ; Wu F; Li JS
Zhonghua Kou Qiang Yi Xue Za Zhi; 2023 Dec; 58(12):1257-1264. PubMed ID: 38061868
[No Abstract] [Full Text] [Related]
17. [Preliminary outcomes of neoadjuvant chemoimmunotherapy combined with transoral robotic surgery for locally advanced oropharyngeal squamous cell carcinoma].
Chen RH; Liang FY; Han P; Lin PL; Lin XJ; Wang JY; Kong XW; Huang XM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):329-334. PubMed ID: 38599642
[No Abstract] [Full Text] [Related]
18. Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.
Ferris RL; Spanos WC; Leidner R; Gonçalves A; Martens UM; Kyi C; Sharfman W; Chung CH; Devriese LA; Gauthier H; Chiosea SI; Vujanovic L; Taube JM; Stein JE; Li J; Li B; Chen T; Barrows A; Topalian SL
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34083421
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial.
Zhang Z; Wu B; Peng G; Xiao G; Huang J; Ding Q; Yang C; Xiong X; Ma H; Shi L; Yang J; Hong X; Wei J; Qin Y; Wan C; Zhong Y; Zhou Y; Zhao X; Leng Y; Zhang T; Wu G; Yao M; Zhang X; Yang K
Clin Cancer Res; 2022 Aug; 28(15):3268-3276. PubMed ID: 35766967
[TBL] [Abstract][Full Text] [Related]
20. [Phase Ⅱ clinical trial of PD-1 inhibitor combined with chemotherapy for locally advanced resectable oral squamous cell carcinoma].
Wang HL; Yue K; Wu YS; Duan YS; Jing C; Wang XD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):335-342. PubMed ID: 38599641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
